Financials Tilray Brands, Inc.

Equities

TLRY

US88688T1007

Pharmaceuticals

Market Closed - Nasdaq 04:00:00 2024-04-26 pm EDT 5-day change 1st Jan Change
1.78 USD +1.71% Intraday chart for Tilray Brands, Inc. +2.89% -22.61%

Valuation

Fiscal Period: May 2021 2022 2023 2024 2025 2026
Capitalization 1 7,736 2,310 1,032 1,378 - -
Enterprise Value (EV) 1 8,186 2,499 1,140 1,556 1,486 1,281
P/E ratio -13.3 x -4.99 x -0.71 x -5.95 x -12.5 x -76.3 x
Yield - - - - - -
Capitalization / Revenue 15.1 x 3.68 x 1.65 x 1.76 x 1.59 x 1.44 x
EV / Revenue 16 x 3.98 x 1.82 x 1.98 x 1.72 x 1.34 x
EV / EBITDA 201 x 52 x 18.5 x 26 x 16.3 x 9.2 x
EV / FCF -97.9 x -11.8 x -88.4 x -19.8 x 66.8 x 18.3 x
FCF Yield -1.02% -8.46% -1.13% -5.06% 1.5% 5.46%
Price to Book - - - 0.52 x - -
Nbr of stocks (in thousands) 464,038 514,375 618,008 774,029 - -
Reference price 2 16.67 4.490 1.670 1.780 1.780 1.780
Announcement Date 7/28/21 7/28/22 7/26/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Mayo 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 179.6 406.6 513.1 628.4 627.1 783.8 865.2 953.9
EBITDA 1 -20.99 12.9 40.77 48.05 61.48 59.92 91.16 139.3
EBIT 1 -109.9 -49.44 -132.2 -142.5 -108.3 -158.2 -107.9 -47.24
Operating Margin -61.22% -12.16% -25.76% -22.68% -17.26% -20.18% -12.47% -4.95%
Earnings before Tax (EBT) 1 -11.85 -60.41 -345 -440.7 -1,450 -198.5 -87.54 -20.15
Net income 1 -12.5 -63.34 -336 -434.1 -1,443 -211.4 -86.3 -27.32
Net margin -6.96% -15.58% -65.49% -69.09% -230.1% -26.97% -9.97% -2.86%
EPS 2 - - -1.250 -0.9000 -2.350 -0.2990 -0.1425 -0.0233
Free Cash Flow 1 -198.1 -199.2 -83.59 -211.3 -12.89 -78.72 22.24 69.94
FCF margin -110.32% -48.99% -16.29% -33.63% -2.06% -10.04% 2.57% 7.33%
FCF Conversion (EBITDA) - - - - - - 24.39% 50.21%
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 8/1/19 7/29/20 7/28/21 7/28/22 7/26/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: May 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 155.2 151.9 153.3 153.2 144.1 145.6 184.2 176.9 193.8 188.3 225.1 210.4 211.1 198.6 233.9
EBITDA 1 13.76 10.09 11.5 13.53 11.71 14.02 22.22 11.43 10.09 10.15 28.06 17.68 18.32 17.68 31.81
EBIT 1 -31.96 -36.29 -38.23 -20.97 -32.55 -29.38 -16.6 -34.36 -41.76 -82.1 -14.19 -23.73 -23.27 -21.64 -11.8
Operating Margin -20.6% -23.89% -24.94% -13.69% -22.58% -20.18% -9.01% -19.42% -21.55% -43.59% -6.3% -11.28% -11.02% -10.89% -5.04%
Earnings before Tax (EBT) 1 0.126 50.64 -461.6 -58.58 -73.35 -1,207 -111.7 -48.6 -49.56 -107.9 -23.7 -33.9 -33.11 -30.3 -21.89
Net income 1 -0.201 43.19 -457.8 -65.79 -61.64 -1,196 -119.8 -55.86 -46.18 -105 -23.07 -32.96 -31.91 -29.2 -21.39
Net margin -0.13% 28.44% -298.58% -42.94% -42.76% -821.32% -65.05% -31.57% -23.83% -55.74% -10.25% -15.66% -15.12% -14.7% -9.15%
EPS 2 - 0.0900 -0.9000 -0.1300 -0.1100 -1.900 -0.1500 -0.1000 -0.0700 -0.1200 -0.0333 -0.0525 -0.0500 -0.0500 -0.0375
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 1/10/22 4/6/22 7/28/22 10/7/22 1/9/23 4/10/23 7/26/23 10/4/23 1/9/24 4/9/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: May 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - 450 190 108 178 109 -
Net Cash position 1 62.4 66.1 - - - - - 96.4
Leverage (Debt/EBITDA) - - 11.04 x 3.952 x 1.754 x 2.971 x 1.19 x -
Free Cash Flow 1 -198 -199 -83.6 -211 -12.9 -78.7 22.2 69.9
ROE (net income / shareholders' equity) -1.15% -4.81% -11.8% -3.35% -37.4% -6.3% -2.3% -0.4%
ROA (Net income/ Total Assets) - -2.96% -8.66% -2.59% -29.6% -4.8% -1.8% -0.3%
Assets 1 - 2,140 3,882 16,775 4,878 4,404 4,795 9,106
Book Value Per Share 2 - - - - - 3.440 - -
Cash Flow per Share 2 - - -0.1700 -0.3700 0.0100 -0.0200 0.0700 0.1100
Capex 1 156 99.1 38.9 34.1 20.8 24.1 23.6 26.8
Capex / Sales 86.86% 24.37% 7.58% 5.42% 3.32% 3.08% 2.73% 2.81%
Announcement Date 8/1/19 7/29/20 7/28/21 7/28/22 7/26/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
1.78 USD
Average target price
2.375 USD
Spread / Average Target
+33.41%
Consensus
  1. Stock Market
  2. Equities
  3. TLRY Stock
  4. Financials Tilray Brands, Inc.